In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Nicolas Danchin
Speaker
Nicolas Danchin
Nicolas Danchin Nicolas Danchin

European Hospital Georges Pompidou, Paris (France)

Specialities : Acute Coronary Syndromes , Acute Cardiac Care, Coronary Artery Disease Chronic

Nicolas Danchin is Professor of Medicine, Consultant Cardiologist and works at the Intensive Cardiac Care Unit of Hôpital Européen Georges Pompidou in Paris, France. He has a special interest in coronary artery disease, its treatment modalities including interventional cardiology and its prevention. Professor Danchin is an Honorary President of the French Society of Cardiology. He is a past-chairman of the Scientific Committee of the French National Health Insurance body. He is also a past Chairman of the Working Group on Acute Cardiac Care of the ESC, and has chaired the Experts’ Committee of the Acute Coronary Syndromes Euro Heart Survey, and the Committee on regulatory affairs of the ESC. He was a member of the Nominating Committee of the ESC from 2008 to 2010. Professor Danchin is the principal investigator of all French nationwide AMI registries 1995-2015 (FAST-MI), and has published >600 papers in PubMed-indexed journals.

41 presentations from this speaker

Contemporary pharmacoinvasive treatment for STEMI

Event : ESC Congress 2019

  • Session : STEMI care today: can we do better?
  • Speaker : N Danchin (Montreuil,FR)
  • Sponsored by Boehringer Ingelheim

Correlates and prognostic significance of nuisance bleeding after acute myocardial infarction. The FAST-MI programme

Event : ESC Congress 2019

  • Session : Coronary artery disease - Epidermiology, prognosis and outcome
  • Speaker : N Danchin (Montreuil,FR)

Diabetes and heart failure after acute myocardial infarction. The FAST-MI programme

Event : ESC Congress 2019

  • Session : Late Breaking Science in Heart Failure 2
  • Speaker : N Danchin (Montreuil,FR)

NOACs in atrial fibrillation: Current landscape in clinical practice

Event : ESC Congress 2019

  • Session : Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI)
  • Speaker : N Danchin (Montreuil,FR)
  • Sponsored by The Bristol-Myers Squibb/Pfizer Alliance

STEMI care today - Closing remarks

Event : ESC Congress 2019

  • Session : STEMI care today: can we do better?
  • Speaker : N Danchin (Montreuil,FR)
  • Sponsored by Boehringer Ingelheim

Changing profile and outcome of AMI patients with previously known coronary artery disease. The FAST-MI programme

Event : ESC Congress 2018

  • Session : Best Posters in non obstructive coronary artery disease
  • Speaker : N Danchin (Montreuil,FR)

Contemporary pharmaco-invasive strategies in the real world.

Event : ESC Congress 2018

  • Session : Spotlights on optimisation of guideline-supported reperfusion strategies for STEMI
  • Speaker : N Danchin (Montreuil,FR)
  • Sponsored by Boehringer Ingelheim

Do we treat too many patients with primary PCI instead of fibrinolysis?

Event : Acute Cardiovascular Care 2018

  • Session : Optimisation of STEMI treatment
  • Speaker : N Danchin (Montreuil,FR)

Moderated discussion - Spotlights on optimisation of guideline-supported reperfusion strategies for STEMI.

Event : ESC Congress 2018

  • Session : Spotlights on optimisation of guideline-supported reperfusion strategies for STEMI
  • Speaker : K Huber (Vienna,AT), R Welsh (Edmonton,CA), N Danchin (Montreuil,FR), JK French (Sydney,AU), AC De Camargo Carvalho (Moema-Sao Paulo,BR)
  • Sponsored by Boehringer Ingelheim

The FAST-MI programme - French registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction

Event : ESC Congress 2018

  • Session : Late Breaking Registry Results 1
  • Speaker : N Danchin (Montreuil,FR)

Type of P2Y12 inhibitor at the acute stage and one-year mortality in acute myocardial infarction. The FAST-MI programme

Event : ESC Congress 2018

  • Session : Oral P2Y12 inhibitors in acute coronary syndromes: are they all equal?
  • Speaker : N Danchin (Montreuil,FR)

Does ticagrelor decrease the risk of recurrent fatal or non-fatal myocardial infarction in real-world settings? The AReMIS case-cohort study

Event : ESC Congress 2017

  • Session : Drug treatment of acute coronary syndrome patients
  • Speaker : N Danchin (Montreuil,FR)

Introduction & remarks.

Event : Heart Failure 2017

  • Session : Management of co-morbidities in heart failure - Exploring new frontiers
  • Speaker : N Danchin (Montreuil,FR)
  • Sponsored by Bayer AG

Are low LDL-c levels associated with higher fasting blood glucose levels? The IPC cohort

Event : ESC Congress 2016

  • Session : Familial hypercholesterolemia and dyslipidaemia
  • Speaker : N Danchin (Montreuil,FR)

Discussion - Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : K Fox (Edinburgh,GB), C Hamm (Bad Nauheim,DE), M Sabatine (Boston,US), N Danchin (Montreuil,FR)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

Dual anti-platelet therapy after acute coronary syndromes – should we continue beyond 12 months? Contra.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : N Danchin (Montreuil,FR)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

Familial hypercholesterolemia is associated with poorer 5-year survival after acute myocardial infarction. The FAST-MI 2005 registry

Event : ESC Congress 2015

  • Session : What does epidemiology teach us about cardiovascular risk?
  • Speaker : N Danchin (Montreuil,FR)

Future direction for research in predicting post infarction outcomes.

Event : ESC Congress 2015

  • Session : Understanding post infarction risk for a better long term survival
  • Speaker : N Danchin (Montreuil,FR)

Pre-hospital fibrinolysis: is it still an option?

Event : Acute Cardiovascular Care 2015

  • Session : Pre-hospital management of ACS
  • Speaker : N Danchin (Montreuil,FR)

Pre-hospital management.

Event : Acute Cardiovascular Care 2015

  • Session : Update in ST-elevation myocardial infarction
  • Speaker : N Danchin (Montreuil,FR)

Chronic periodontal and tooth diseases and cardiovascular mortality in France: the IPC cohort

Event : ESC Congress 2014

  • Session : Novel insights into lifestyle and cardiovascular prevention
  • Speaker : N Danchin (Montreuil,FR)

Coffee or tea consumption: no impact on cardiovascular mortality: the IPC cohort

Event : ESC Congress 2014

  • Session : Novel insights into lifestyle and cardiovascular prevention
  • Speaker : N Danchin (Montreuil,FR)

Optimal medical treatment: what do the Guidelines say?

Event : ESC Congress 2014

  • Session : Cardio-diabetology or diabeto-cardiology
  • Speaker : N Danchin (Montreuil,FR)

Panel discussion: pharmaco-invasive vs. primary PCI.

Event : ESC Congress 2014

  • Session : STEMI 2014: aligning optimal care to time, place and person
  • Speaker : N Danchin (Montreuil,FR), PW Armstrong (Alberta,CA), F Van de Werf (Leuven,BE), K Huber (Vienna,AT), Y Lambert (Le Chesnay,FR), A Galyavich (Kazan,RU)
  • Sponsored by Boehringer Ingelheim

Perceived stress and 6-year incidence of high blood pressure in relation to sex and occupational status: the IPC cohort study

Event : ESC Congress 2014

  • Session : Environment and cardiovascualr diseases
  • Speaker : N Danchin (Montreuil,FR)

Clinical research in acute coronary syndrome: the role of registries.

Event : ESC Congress 2013

  • Session : Acute cardiovascular care: a multidisciplinary endeavour
  • Speaker : N Danchin (Montreuil,FR)

FAST-MI: Pharmaco-invasive strategy versus primary PCI for STEMI. Five-year results of the FAST-MI registry.

Event : ESC Congress 2013

  • Session : Registry Hot Line: Registries on prevention and treatment
  • Speaker : N Danchin (Montreuil,FR)

Risk stratification in acute coronary syndromes: is there still room for improvement? Case study.

Event : ESC Congress 2013

  • Session : Cases on optimising oral antiplatelet therapy in the management of acute coronary syndromes
  • Speaker : N Danchin (Montreuil,FR)
  • Sponsored by AstraZeneca

The dedicated European registry for quality assessment.

Event : ESC Congress 2013

  • Session : Quality indicators for acute cardiac care
  • Speaker : N Danchin (Montreuil,FR)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are